Sign in
SC 13G

Amended Statement of Ownership

AN2 Therapeutics, Inc. Filed Acc 0001193125-24-091977

Stakes reported in this filing

Reporting person Shares Of the class
James N. Topper 1,488,889 5.0%
Patrick J. Heron 1,488,889 5.0%
Albert Cha 1,145,779 3.8%
James Brush 1,145,779 3.8%
Frazier Life Sciences Public Fund, L.P. 707,879 2.4%
FHMLSP, L.P. 707,879 2.4%
FHMLSP, L.L.C. 707,879 2.4%
Frazier Life Sciences Public Overage Fund, L.P. 437,900 1.5%
FHMLSP Overage, L.P. 437,900 1.5%
FHMLSP Overage, L.L.C. 437,900 1.5%
Frazier Life Sciences XI, L.P. 282,177 0.9%
FHMLS XI, L.P. 282,177 0.9%
FHMLS XI, L.L.C. 282,177 0.9%
Daniel Estes 282,177 0.9%
Frazier Life Sciences X, L.P. 60,933 0.2%
FHMLS X, L.P. 60,933 0.2%
FHMLS X, L.L.C. 60,933 0.2%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading d816254dsc13g.htm…